Isoliquiritigenin attenuates cisplatin-induced hearing loss and ototoxicity by activating the Keap1-Nrf2-ARE pathway

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 98f087a98d97ac07-IAD IP: 47.97.18.252 UTC time: 2025-10-15T16:00:32+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

Comments (0)

No login
gif